血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2016427)
◆英語タイトル:Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016427
◆発行日:2019年11月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥216,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥648,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)のフェーズ3治験薬の状況
・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)治療薬の市場規模(販売予測)
・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)のフェーズ3治験薬分析
・開発中止中の血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Thrombotic Thrombocytopenic Purpura Report is to understand the market and pipeline status of the drugs around the Thrombotic Thrombocytopenic Purpura to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2020. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Thrombotic Thrombocytopenic Purpura. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for Thrombotic Thrombocytopenic Purpura.
• A review of the marketed products under prescription for Thrombotic Thrombocytopenic Purpura, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Thrombotic Thrombocytopenic Purpura with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Thrombotic Thrombocytopenic Purpura drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Thrombotic Thrombocytopenic Purpura drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Thrombotic Thrombocytopenic Purpura drugs.
• Coverage of Thrombotic Thrombocytopenic Purpura Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2020.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2020
6. Marketed Drugs for Thrombotic Thrombocytopenic Purpura
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Thrombotic Thrombocytopenic Purpura
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Thrombotic Thrombocytopenic Purpura
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, Marketed Drugs by Application Type, 2018
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, Marketed Drugs by Marketing Status, 2018
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, (Year), 2018
• Thrombotic Thrombocytopenic Purpura Marketed Drugs, API Manufacturers by US DMF Status, 2018
• Thrombotic Thrombocytopenic Purpura Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, Europe by Country, 2018
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, India by State, 2018
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, China by Province, 2018
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers by Geography 2018
• Thrombotic Thrombocytopenic Purpura Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, Global Sales-2020 (in million USD)
• API Manufacturers for Drug, 2018
• Phase III Drugs for Thrombotic Thrombocytopenic Purpura, 2018
• Discontinued Drugs for Thrombotic Thrombocytopenic Purpura, 2018


List of Figures
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, Marketed Drugs by Application Type (%), 2018
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2018
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, US, (Year), 2018
• Thrombotic Thrombocytopenic Purpura Marketed Drugs, API Manufacturers by US DMF Status (%), 2018
• Thrombotic Thrombocytopenic Purpura Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, Europe by Country, 2018
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, India by State, 2018
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers, China by Province, 2018
• Thrombotic Thrombocytopenic Purpura Drugs, API Manufacturers by Geography 2018
• Thrombotic Thrombocytopenic Purpura Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Thrombotic Thrombocytopenic Purpura Therapeutic Market, Global Sales 2020 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2018


*** レポートのキーワード ***

血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界及び中国のエネルギー管理機器市場2016
    The 'Global and Chinese Energy Management Devices Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Energy Management Devices industry with a focus on the Chinese market. The report provides key statistics on the market status of the …
  • 産後出血(PPH)治療機器の世界市場2016
    The Global Postpartum Hemorrhage (PPH) Treatment Devices Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Postpartum Hemorrhage (PPH) Treatment Devices industry. Firstly, the report provides a basic overview of the industry including definitions, …
  • プロピレングリコールの世界市場2016
    The Global Propylene Glycol Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Propylene Glycol industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure …
  • 世界及び中国のラウロイルクロリド市場2016
    The 'Global and Chinese Lauric Chloride Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Lauric Chloride industry with a focus on the Chinese market. The report provides key statistics on the market status of the Lauric Chloride manu …
  • 世界の吸着剤市場2016
    2016 Global Adsorbents Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Adsorbents industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report …
  • 世界の半透明シリコン窒化物セラミックス市場2017
    Translucent Silicon Nitride Ceramics Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main coun …
  • 世界の工業用誘導加熱装置市場2016
    Notes:Production, means the output of Industrial Induction Heater Revenue, means the sales value of Industrial Induction Heater This report studies Industrial Induction Heater in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers …
  • 世界及び中国のセパレート式コンクリート打設ブーム市場2016
    The 'Global and Chinese Separate Placing Boom Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Separate Placing Boom industry with a focus on the Chinese market. The report provides key statistics on the market status of the Separate …
  • Angiox:医薬品の世界市場2016
    DelveInsight Drug Report, “Angiox- Drug Insights, 2016” highlights the Angiox marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Angiox covering the total sales estimation and also provides …
  • 世界のミルタザピン中間体市場2017
    Mirtazapine Intermediate Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United State …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016427 )"血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。